Xiaojing Cao

机构：Guangzhou University of Chinese Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, National Clinical Research

发表论文 54 篇 · 总被引 958 次 · h-index 18

代表论文

• Efficacy and Safety of Thermal Ablation for Treatment of Solitary T1N0M0 Papillary Thyroid Carcinoma: A Multicenter Retrospective Study (2021 · Radiology · 被引 111)
• Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study (2021 · The Journal of Clinical Endocrinology & Metabolism · 被引 61)
• Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma (2023 · Hepatology International · 被引 60)
• Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (2022 · Frontiers in Immunology · 被引 51)
• Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation (2021 · CardioVascular and Interventional Radiology · 被引 22)
• Inhibition of the lncRNA DANCR attenuates cardiomyocyte injury induced by oxygen-glucose deprivation via the miR-19a-3p/MAPK1 axis (2021 · Acta Biochimica et Biophysica Sinica · 被引 18)